Skip to main content
PMC home page
Journal of Psychiatry & Neuroscience : JPN logoLink to Journal of Psychiatry & Neuroscience : JPN
. 1997 Nov;22(5):318–326.

Post-traumatic stress disorder and serotonin: new directions for research and treatment.

L L Davis 1, A Suris 1, M T Lambert 1, C Heimberg 1, F Petty 1
PMCID: PMC1188879  PMID: 9401312

Abstract

The overlap in clinical phenomenology and morbidity between post-traumatic stress disorder (PTSD) and such conditions as major depression, anxiety disorders and aggression, in which a serotonin dysfunction is implicated, suggests a role for serotonin in the pathophysiology of PTSD. In this paper, we review current knowledge concerning the role of serotonergic mechanisms and interventions in PTSD. Since there is no clearly effective pharmacologic intervention for this disorder, the underlying neurochemical dysfunction needs to be carefully defined so that more effective treatment can be developed. Preclinical and clinical studies of the serotonergic mechanisms in the pathophysiology of PTSD and treatment trials involving serotonergic agents are limited, but indicate considerable promise. Further investigation of a serotonergic dysfunction in PTSD and of its treatment with serotonergic agents is warranted.

Full text

PDF
325

Images in this article

320Fig. 1
on p.320

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arora R. C., Fichtner C. G., O'Connor F., Crayton J. W. Paroxetine binding in the blood platelets of post-traumatic stress disorder patients. Life Sci. 1993;53(11):919–928. doi: 10.1016/0024-3205(93)90444-8. [DOI] [PubMed] [Google Scholar]
  2. Blank A. S., Jr Clinical detection, diagnosis, and differential diagnosis of post-traumatic stress disorder. Psychiatr Clin North Am. 1994 Jun;17(2):351–383. [PubMed] [Google Scholar]
  3. Brady K. T., Sonne S. C., Roberts J. M. Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence. J Clin Psychiatry. 1995 Nov;56(11):502–505. [PubMed] [Google Scholar]
  4. Bremner J. D., Innis R. B., Ng C. K., Staib L. H., Salomon R. M., Bronen R. A., Duncan J., Southwick S. M., Krystal J. H., Rich D. Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder. Arch Gen Psychiatry. 1997 Mar;54(3):246–254. doi: 10.1001/archpsyc.1997.01830150070011. [DOI] [PubMed] [Google Scholar]
  5. Bremner J. D., Randall P., Scott T. M., Bronen R. A., Seibyl J. P., Southwick S. M., Delaney R. C., McCarthy G., Charney D. S., Innis R. B. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry. 1995 Jul;152(7):973–981. doi: 10.1176/ajp.152.7.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bremner J. D., Randall P., Vermetten E., Staib L., Bronen R. A., Mazure C., Capelli S., McCarthy G., Innis R. B., Charney D. S. Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse--a preliminary report. Biol Psychiatry. 1997 Jan 1;41(1):23–32. doi: 10.1016/s0006-3223(96)00162-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brown G. L., Linnoila M. I. CSF serotonin metabolite (5-HIAA) studies in depression, impulsivity, and violence. J Clin Psychiatry. 1990 Apr;51 (Suppl):31–43. [PubMed] [Google Scholar]
  8. Chen C. J. The obsessive quality and clomipramine treatment in PTSD. Am J Psychiatry. 1991 Aug;148(8):1087–1088. doi: 10.1176/ajp.148.8.1087. [DOI] [PubMed] [Google Scholar]
  9. Copenhaver J. H., Schalock R. L., Johnson L., Stull T., Pankratz T. Relationship between preexposure to prey and PCPA-induced filicidal activity in Sprague-Dawley rats. Physiol Behav. 1989 Feb;45(2):343–346. doi: 10.1016/0031-9384(89)90137-6. [DOI] [PubMed] [Google Scholar]
  10. De Boer M., Op den Velde W., Falger P. J., Hovens J. E., De Groen J. H., Van Duijn H. Fluvoxamine treatment for chronic PTSD: a pilot study. Psychother Psychosom. 1992;57(4):158–163. doi: 10.1159/000288593. [DOI] [PubMed] [Google Scholar]
  11. Dubovsky S. L. Beyond the serotonin reuptake inhibitors: rationales for the development of new serotonergic agents. J Clin Psychiatry. 1994 Feb;55 (Suppl):34–44. [PubMed] [Google Scholar]
  12. Duffy J. D., Malloy P. F. Efficacy of buspirone in the treatment of posttraumatic stress disorder: an open trial. Ann Clin Psychiatry. 1994 Mar;6(1):33–37. doi: 10.3109/10401239409148837. [DOI] [PubMed] [Google Scholar]
  13. Graeff F. G., Guimarães F. S., De Andrade T. G., Deakin J. F. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav. 1996 May;54(1):129–141. doi: 10.1016/0091-3057(95)02135-3. [DOI] [PubMed] [Google Scholar]
  14. Handelsman L., Holloway K., Kahn R. S., Sturiano C., Rinaldi P. J., Bernstein D. P., Siever L., Gabriel S., Cooper T. B. Hostility is associated with a low prolactin response to meta-chlorophenylpiperazine in abstinent alcoholics. Alcohol Clin Exp Res. 1996 Aug;20(5):824–829. doi: 10.1111/j.1530-0277.1996.tb05258.x. [DOI] [PubMed] [Google Scholar]
  15. Higley J. D., King S. T., Jr, Hasert M. F., Champoux M., Suomi S. J., Linnoila M. Stability of interindividual differences in serotonin function and its relationship to severe aggression and competent social behavior in rhesus macaque females. Neuropsychopharmacology. 1996 Jan;14(1):67–76. doi: 10.1016/S0893-133X(96)80060-1. [DOI] [PubMed] [Google Scholar]
  16. Hiley-Young B., Blake D. D., Abueg F. R., Rozynko V., Gusman F. D. Warzone violence in Vietnam: an examination of premilitary, military, and postmilitary factors in PTSD in-patients. J Trauma Stress. 1995 Jan;8(1):125–141. doi: 10.1007/BF02105411. [DOI] [PubMed] [Google Scholar]
  17. Kessler R. C., Sonnega A., Bromet E., Hughes M., Nelson C. B. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995 Dec;52(12):1048–1060. doi: 10.1001/archpsyc.1995.03950240066012. [DOI] [PubMed] [Google Scholar]
  18. LaPorta L. D., Ware M. R. Buspirone in the treatment of posttraumatic stress disorder. J Clin Psychopharmacol. 1992 Apr;12(2):133–134. doi: 10.1097/00004714-199204000-00010. [DOI] [PubMed] [Google Scholar]
  19. Lambert M. T., Hendrickse W., Andrews R., Zelanko J., Fowler D. R. Malignant Post-Vietnam Stress Syndrome revisited. J Nerv Ment Dis. 1996 Jun;184(6):354–357. doi: 10.1097/00005053-199606000-00004. [DOI] [PubMed] [Google Scholar]
  20. Lasko N. B., Gurvits T. V., Kuhne A. A., Orr S. P., Pitman R. K. Aggression and its correlates in Vietnam veterans with and without chronic posttraumatic stress disorder. Compr Psychiatry. 1994 Sep-Oct;35(5):373–381. doi: 10.1016/0010-440x(94)90278-x. [DOI] [PubMed] [Google Scholar]
  21. Linnoila V. M., Virkkunen M. Aggression, suicidality, and serotonin. J Clin Psychiatry. 1992 Oct;53 (Suppl):46–51. [PubMed] [Google Scholar]
  22. Manev H., Pericić D., Mück-Seler D. Inhibitory influence of dihydroergosine on the aggressiveness of rats and mice. Pharmacol Biochem Behav. 1989 Jan;32(1):111–115. doi: 10.1016/0091-3057(89)90218-9. [DOI] [PubMed] [Google Scholar]
  23. Mann J. J., Malone K. M., Diehl D. J., Perel J., Cooper T. B., Mintun M. A. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry. 1996 Feb;153(2):174–182. doi: 10.1176/ajp.153.2.174. [DOI] [PubMed] [Google Scholar]
  24. March J. S. Fluoxetine and fluvoxamine in PTSD. Am J Psychiatry. 1992 Mar;149(3):413–413. doi: 10.1176/ajp.149.3.413. [DOI] [PubMed] [Google Scholar]
  25. Marmar C. R., Schoenfeld F., Weiss D. S., Metzler T., Zatzick D., Wu R., Smiga S., Tecott L., Neylan T. Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder. J Clin Psychiatry. 1996;57 (Suppl 8):66–72. [PubMed] [Google Scholar]
  26. McDougle C. J., Southwick S. M., Charney D. S., St James R. L. An open trial of fluoxetine in the treatment of posttraumatic stress disorder. J Clin Psychopharmacol. 1991 Oct;11(5):325–327. [PubMed] [Google Scholar]
  27. Mellman T. A., Kumar A. M. Platelet serotonin measures in posttraumatic stress disorder. Psychiatry Res. 1994 Jul;53(1):99–101. doi: 10.1016/0165-1781(94)90098-1. [DOI] [PubMed] [Google Scholar]
  28. Moeller F. G., Dougherty D. M., Swann A. C., Collins D., Davis C. M., Cherek D. R. Tryptophan depletion and aggressive responding in healthy males. Psychopharmacology (Berl) 1996 Jul;126(2):97–103. doi: 10.1007/BF02246343. [DOI] [PubMed] [Google Scholar]
  29. Nagy L. M., Morgan C. A., 3rd, Southwick S. M., Charney D. S. Open prospective trial of fluoxetine for posttraumatic stress disorder. J Clin Psychopharmacol. 1993 Apr;13(2):107–113. [PubMed] [Google Scholar]
  30. O'Keane V., Moloney E., O'Neill H., O'Connor A., Smith C., Dinan T. G. Blunted prolactin responses to d-fenfluramine in sociopathy. Evidence for subsensitivity of central serotonergic function. Br J Psychiatry. 1992 May;160:643–646. doi: 10.1192/bjp.160.5.643. [DOI] [PubMed] [Google Scholar]
  31. Orsillo S. M., Weathers F. W., Litz B. T., Steinberg H. R., Huska J. A., Keane T. M. Current and lifetime psychiatric disorders among veterans with war zone-related posttraumatic stress disorder. J Nerv Ment Dis. 1996 May;184(5):307–313. doi: 10.1097/00005053-199605000-00007. [DOI] [PubMed] [Google Scholar]
  32. Rothbaum B. O., Ninan P. T., Thomas L. Sertraline in the treatment of rape victims with posttraumatic stress disorder. J Trauma Stress. 1996 Oct;9(4):865–871. doi: 10.1007/BF02104108. [DOI] [PubMed] [Google Scholar]
  33. Shalev A. Y., Bonne O., Eth S. Treatment of posttraumatic stress disorder: a review. Psychosom Med. 1996 Mar-Apr;58(2):165–182. doi: 10.1097/00006842-199603000-00012. [DOI] [PubMed] [Google Scholar]
  34. Shin L. M., Kosslyn S. M., McNally R. J., Alpert N. M., Thompson W. L., Rauch S. L., Macklin M. L., Pitman R. K. Visual imagery and perception in posttraumatic stress disorder. A positron emission tomographic investigation. Arch Gen Psychiatry. 1997 Mar;54(3):233–241. doi: 10.1001/archpsyc.1997.01830150057010. [DOI] [PubMed] [Google Scholar]
  35. Solomon S. D., Gerrity E. T., Muff A. M. Efficacy of treatments for posttraumatic stress disorder. An empirical review. JAMA. 1992 Aug 5;268(5):633–638. [PubMed] [Google Scholar]
  36. Southwick S. M., Bremner D., Krystal J. H., Charney D. S. Psychobiologic research in post-traumatic stress disorder. Psychiatr Clin North Am. 1994 Jun;17(2):251–264. [PubMed] [Google Scholar]
  37. Southwick S. M., Yehuda R., Giller E. L., Jr Personality disorders in treatment-seeking combat veterans with posttraumatic stress disorder. Am J Psychiatry. 1993 Jul;150(7):1020–1023. doi: 10.1176/ajp.150.7.1020. [DOI] [PubMed] [Google Scholar]
  38. Sutherland S. M., Davidson J. R. Pharmacotherapy for post-traumatic stress disorder. Psychiatr Clin North Am. 1994 Jun;17(2):409–423. [PubMed] [Google Scholar]
  39. Vergnes M., Depaulis A., Boehrer A., Kempf E. Selective increase of offensive behavior in the rat following intrahypothalamic 5,7-DHT-induced serotonin depletion. Behav Brain Res. 1988 Jul;29(1-2):85–91. doi: 10.1016/0166-4328(88)90055-1. [DOI] [PubMed] [Google Scholar]
  40. Wells B. G., Chu C. C., Johnson R., Nasdahl C., Ayubi M. A., Sewell E., Statham P. Buspirone in the treatment of posttraumatic stress disorder. Pharmacotherapy. 1991;11(4):340–343. [PubMed] [Google Scholar]
  41. van der Kolk B. A., Dreyfuss D., Michaels M., Shera D., Berkowitz R., Fisler R., Saxe G. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry. 1994 Dec;55(12):517–522. [PubMed] [Google Scholar]

Articles from Journal of Psychiatry and Neuroscience are provided here courtesy of Canadian Medical Association

RESOURCES